Katherine Baney

Title: Katherine Baney: Innovator in Immunotherapy

Introduction

Katherine Baney is a prominent inventor based in Berkeley, CA. She has made significant contributions to the field of immunotherapy, holding a total of 5 patents. Her work focuses on developing innovative systems and methods that enhance the effectiveness of immunotherapy treatments.

Latest Patents

Katherine's latest patents include groundbreaking advancements in immunotherapy. One notable patent is for "Compositions and methods for use in immunotherapy," which details CasX:gNA systems. These systems comprise CasX proteins, guide nucleic acids (gNAs), and optionally donor template nucleic acids. They are designed for modifying cell genes that encode proteins involved in antigen processing, presentation, recognition, and response. Additionally, the modified cells may express chimeric antigen receptors (CAR) or engineered T cell receptors (TCR), making them valuable for preparing cells for immunotherapy. Another patent focuses on "Guide scaffolds," which are reference guide nucleic acid scaffolds capable of binding engineered proteins with a RuvC cleavage domain. These variants exhibit improved characteristics compared to the original scaffolds.

Career Highlights

Katherine Baney has established herself as a leading figure in her field through her innovative research and patent contributions. She is currently associated with Scribe Therapeutics Inc., where she continues to advance her work in immunotherapy.

Collaborations

Katherine collaborates with talented individuals such as Sarah Denny and Hannah Spinner, contributing to a dynamic research environment that fosters innovation.

Conclusion

Katherine Baney's work in immunotherapy exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations highlight her commitment to advancing treatment options for patients.